SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

RenovoRx, Inc.
Date: Aug. 28, 2025 · CIK: 0001574094 · Accession: 0000000000-25-009230

Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-40738

Date
August 28, 2025
Author
Finance
Form
UPLOAD
Company
RenovoRx, Inc.

Letter

Re: RenovoRx, Inc. Form 10-K for the fiscal year ended December 31, 2024 File No. 001-40738 Dear Ronald B. Kocak:

August 28, 2025

Ronald B. Kocak VP Controller and Principal Accounting Officer RenovoRx, Inc. 2570 West El Camino Real, Suite 320 Mountain View, California 94040

We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 August 28, 2025

Ronald B. Kocak
VP Controller and Principal Accounting Officer
RenovoRx, Inc.
2570 West El Camino Real, Suite 320
Mountain View, California 94040

 Re: RenovoRx, Inc.
 Form 10-K for the fiscal year ended December 31, 2024
 File No. 001-40738
Dear Ronald B. Kocak:

 We have completed our review of your filings. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
</TEXT>
</DOCUMENT>